Clinical trials: Nontraumatic Intracerebral Hemorrhage, Multiple Localized

Nontraumatic Intracerebral Hemorrhage, Multiple Localized

Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)

• Withdrawn
• Age: 18 years and older
• Phase 4

Intracerebral hemorrhage (ICH) is responsible for 10-15% of primary strokes. ICH is a dynamic process with three phases: initial hemorrhage, followed by hematoma expansion and perihematoma edema formation.

Trial name

Clevidipine (NCT03300479)

Testing

Clevidipine, Urapidil

Where

Switzerland

Sponsor

University of Zurich